Case Reports

Recurrent pseudogout after therapy with immune checkpoint inhibitors: a case report with immunoprofiling of synovial fluid at each flare
Sang T. Kim, Mohamad Bittar, Hyun J. Kim, Sattva S. Neelapu, Amado J. Zurita, Roza Nurieva, Maria E. Suarez-Almazor

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 126; DOI: 10.1186/s40425-019-0597-x
Two cases of intrahepatic cholangiocellular carcinoma with high insertion-deletion ratios that achieved a complete response following chemotherapy combined with PD-1 blockade
Minghao Sui, Yu Li, Hongguang Wang, Ying Luo, Tao Wan, Xun Wang, Bingyang Hu, Yanshuang Cheng, Xianrong Lv, Xianlei Xin, Qiang Xu, Guan Wang, Shichun Lu

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 125; DOI: 10.1186/s40425-019-0596-y
Pneumonitis resulting from radiation and immune checkpoint blockade illustrates characteristic clinical, radiologic and circulating biomarker features
Jonathan D. Schoenfeld, Mizuki Nishino, Mariano Severgnini, Michael Manos, Raymond H. Mak, F. Stephen Hodi

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 112; DOI: 10.1186/s40425-019-0583-3
Severe cytokine release syndrome resulting in purpura fulminans despite successful response to nivolumab therapy in a patient with pleomorphic carcinoma of the lung: a case report
Osamu Honjo, Terufumi Kubo, Fumiko Sugaya, Takahiro Nishizaka, Koji Kato, Yoshihiko Hirohashi, Hiroki Takahashi, Toshihiko Torigoe

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 97; DOI: 10.1186/s40425-019-0582-4
Complete response of renal cell carcinoma vena cava tumor thrombus to neoadjuvant immunotherapy
Craig Labbate, Ken Hatogai, Ryan Werntz, Walter M. Stadler, Gary D. Steinberg, Scott Eggener, Randy F. Sweis

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 66; DOI: 10.1186/s40425-019-0546-8
Exceptional response and multisystem autoimmune-like toxicities associated with the same T cell clone in a patient with uveal melanoma treated with immune checkpoint inhibitors
Suthee Rapisuwon, Benjamin Izar, Cory Batenchuk, Alexandre Avila, Shaolin Mei, Peter Sorger, Jerry M. Parks, Connor J. Cooper, David Wagner, Jay C. Zeck, Aline J. Charabaty, Michael B. Atkins

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 61; DOI: 10.1186/s40425-019-0533-0
Intralymphatic histiocytosis in a patient with lung adenocarcinoma treated with pembrolizumab: a case report
Teppei Sugano, Masahiro Seike, Yoko Funasaka, Mai Yoshida, Ryoko Takayama, Ken Okamura, Asuka Nakanishi, Toru Tanaka, Susumu Takeuchi, Rintaro Noro, Yuji Minegishi, Kaoru Kubota, Hidehisa Saeki, Akihiko Gemma

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 59; DOI: 10.1186/s40425-019-0534-z
A good response of refractory mantel cell lymphoma to haploidentical CAR T cell therapy after failure of autologous CAR T cell therapy
Tongjuan Li, Yuanyuan Zhang, Dan Peng, Xia Mao, Xiaoxi Zhou, Jianfeng Zhou

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 51; DOI: 10.1186/s40425-019-0529-9
Inflammation-induced hypoparathyroidism triggered by combination immune checkpoint blockade for melanoma
Beckey Trinh, Guacimara Ortega Sanchez, Petra Herzig, Heinz Läubli

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 52; DOI: 10.1186/s40425-019-0528-x
Acute liver injury in the context of immune checkpoint inhibitor-related colitis treated with infliximab
Hao Chi Zhang, Wenyi Luo, Yinghong Wang

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 47; DOI: 10.1186/s40425-019-0532-1

Main menu

Case Reports

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Case Reports

Pages